Generic nintedanib reached US pharmacies in August 2026. Here is what 60 capsules — 30 days — of brand and generic cost in eight places.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Ofev 150 mg (nintedanib) is taken twice a day for idiopathic pulmonary fibrosis and other fibrosing lung diseases (FDA label) — so 30 days = 60 capsules, which is also the European pack size. Where a generic is listed, we show it as well. US dollars at European Central Bank reference rates of November 6, 2026. The price types differ — list price, negotiated price, pharmacy acquisition cost, retail price — and are labelled.
OFEV / NINTEDANIB 150 MG · 30 DAYS = 60 CAPSULES
Price by country, November 2026
Brand Ofev unless marked generic. US list price: CMS figure for a 30-day supply (2024). No official price in Germany.
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (list, 2024) | Ofev $12,622 for a 30-day supply (CMS, 2024) | $12,622 | Commercially insured patients may get Ofev for as little as $0 a month; not for Medicare, Medicaid or cash payers (maker’s terms) |
| 🇺🇸 United States (pharmacy cost) | Generic nintedanib 150 mg $12.05711 per capsule (CMS NADAC, Nov 4, 2026); Ofev not in the survey | generic $723 | — |
| 🇺🇸 United States (Medicare, 2027) | Ofev $6,350 negotiated price per 30-day supply, from Jan 1, 2027 (CMS); $108.972348 per capsule | $6,538 | Depends on the Part D plan and coverage phase |
| 🇬🇧 United Kingdom | Ofev £2,151.10 for 60 capsules (NHS price, since Sep 24, 2015); generics £1,505.77 to £2,151.10 | $2,879 | £9.90 per item in England; free in Scotland, Wales and Northern Ireland |
| 🇨🇭 Switzerland | Ofev CHF 1,577.15 for 60 capsules; generic from CHF 295.65 (public prices; limitation) | $1,926 (generic $361) | 40% share for Ofev, 10% for the generic, after the annual deductible |
| 🇫🇷 France | Ofev €1,313.61 for 60 capsules; generic €607.14 (official prices excluding dispensing fee) | $1,467 (generic $678) | 70% of the price unless a complementary insurer covers it (30% reimbursed) |
| 🇳🇱 Netherlands | Ofev €2,226.88 for 60 capsules; generic (Viatris) €1,397.38 (average pharmacy prices) | $2,486 (generic $1,560) | Fully reimbursed; counts toward the annual deductible |
| 🇦🇹 Austria | Ofev €2,268.90 for 60 capsules; generic from €450.65 (social-insurance prices excl. VAT) | $2,533 (generic $503) | €7.55 prescription fee per pack; Ofev needs insurer approval first |
| 🇩🇪 Germany | No statutory price ceiling (Festbetrag) for nintedanib; no official price found | — | — |
We compare prices; we do not recommend where to buy medicine. Whether to switch between brand and generic is a decision for your doctor and pharmacist.
The $6,350 is the price Medicare negotiated for Ofev under the Inflation Reduction Act, effective January 1, 2027; CMS’s data file sets $108.972348 per capsule, or $6,538 for 60 (our calculation). Generic nintedanib 150 mg cost US pharmacies $12.05711 per capsule in November 2026 — $723 for 60, or 11% of Medicare’s 2027 price for the brand (our calculation: $723 ÷ $6,538). In 2024 about 24,000 people with Medicare Part D used Ofev, and Part D spent $2.09 billion on it before rebates (CMS).
France, Switzerland, the Netherlands, Austria and the UK publish an official price for Ofev 150 mg — about $1,467 to $2,879 for 60 capsules at ECB rates, or 12% to 23% of the 2024 US list price (our calculation: $1,467 ÷ $12,622 and $2,879 ÷ $12,622). Generics are listed at CHF 295.65 in Switzerland, €450.65 in Austria and €607.14 in France.
In 2019 the Joint Federal Committee (G-BA) found a hint of considerable added benefit of nintedanib over best supportive care for adults with idiopathic pulmonary fibrosis. Nintedanib has no Festbetrag, and we found no freely published official German price.
CMS recorded a list price of $12,622 for a 30-day supply in 2024; Medicare’s negotiated price from January 1, 2027 is $6,350 (CMS). In Europe, 60 capsules of Ofev 150 mg cost €1,313.61 in France, CHF 1,577.15 in Switzerland, €2,226.88 in the Netherlands, €2,268.90 in Austria (excl. VAT) and £2,151.10 in the UK — about $1,467 to $2,879 at ECB rates.
Yes. Generic nintedanib 150 mg appears in the US pharmacy price survey from August 19, 2026, at $12.05711 per capsule by November (NADAC). In Europe, generics are listed from CHF 295.65 for 60 capsules in Switzerland, €450.65 in Austria, €607.14 in France and £1,505.77 in the UK.
The negotiated price applies to the brand, Ofev: $108.972348 per capsule from January 1, 2027 (CMS). It was set before the generic reached US pharmacies; in November 2026 pharmacies paid $12.05711 per generic capsule (NADAC).
In the US, commercially insured patients may get Ofev for as little as $0 a month through the maker’s program, which excludes Medicare, Medicaid and cash payers. In England each prescription item costs £9.90; in Switzerland insured patients pay 40% for Ofev and 10% for a generic after the deductible; in France 30% is reimbursed; in Austria a €7.55 prescription fee; in the Netherlands it is fully reimbursed but counts toward the annual deductible.
The label dose is 150 mg twice a day, about 12 hours apart with food — 60 capsules for 30 days (FDA label).
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; currency conversions and 30-day figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
